ELEV NASDAQ
Elevation Oncology, Inc.
1W: +0.0%
1M: -3.6%
3M: +7.3%
1Y: -86.7%
3Y: -74.1%
$0.36
Last traded 2025-08-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$24K
+38.5% ▲
Operating Income
-$45M
+1.6% ▲
Net Income
-$44M
+2.7% ▲
EPS (Diluted)
$-0.78
+41.8% ▲
EBITDA
-$45M
-7.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $15K | $18K | $27K | $39K | $24K |
| Gross Profit | -$15K | -$18K | -$27K | -$39K | -$24K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $15M | $24M | $79M | $25M | $29M |
| SG&A Expenses | $2M | $8M | $16M | $15M | $16M |
| Operating Expenses | $17M | $32M | $95M | $45M | $45M |
| Operating Income | -$17M | -$32M | -$95M | -$45M | -$45M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $479K | $4M | $4M |
| Income Before Tax | -$17M | -$32M | -$95M | -$46M | -$44M |
| Tax Expense | $0 | $0 | $25K | $30K | $43K |
| Net Income | -$17M | -$32M | -$95M | -$46M | -$44M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.73 | $-1.38 | $-4.09 | $-1.34 | $-0.78 |
| EBITDA | -$17M | -$32M | -$95M | -$41M | -$45M |
| Shares Outstanding | 24M | 23M | 23M | 34M | 57M |